sentence1
stringlengths
1.08k
96.5k
sentence2
stringlengths
51
966
labels
stringclasses
3 values
metadata
stringlengths
123
2.56k
TITLE: Laparoscopic closure of perforated gastro-duodenal ulcer: 15 years’ experience in our centre ABSTRACT.INTRODUCTION: The objective of the study is to share the results and development findings on the laparoscopic closure technique applied in our centre during a 15-year period (1998–2012). ABSTRACT.AIM: ...
Intervention: laparoscopy within the group with ASA 1–3 Comparator: conventional surgery Outcome: duration of hospitalization
-1
{"evidence_spans": [{"end": 1058, "start": 826, "text": "T.RESULTS:\r\nThe results favour laparoscopy within the group with ASA 1\u20133 in terms of several parameters, namely: duration of hospitalization \u2013 7.7 days in the case of laparoscopic intervention, vs. 10.6 days for conventional surgery"}], "id": "2569", ...
TITLE: Laparoscopic closure of perforated gastro-duodenal ulcer: 15 years’ experience in our centre ABSTRACT.INTRODUCTION: The objective of the study is to share the results and development findings on the laparoscopic closure technique applied in our centre during a 15-year period (1998–2012). ABSTRACT.AIM: ...
Intervention: laparoscopy within the group with ASA 4–5 Comparator: conventional surgery Outcome: Total morbidity
-1
{"evidence_spans": [{"end": 1261, "start": 1132, "text": "(p < 0.05). Total morbidity was 27.5% in the case of patients with conventional surgery, vs. 10.9% with laparoscopic intervention"}, {"end": 1333, "start": 1132, "text": "(p < 0.05). Total morbidity was 27.5% in the case of patients with conventional surgery, vs...
TITLE: Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial ABSTRACT.BACKGROUND: Extended use of combined pharmacotherapies to treat tobacco dependence may increase smoking abstinence; few studies have examined their...
Intervention: standard nicotine patch (NRT), extended use of combined formulations of nicotine replacement therapy (NRT+) Comparator: varenicline (VR) Outcome: carbon monoxide-confirmed continuous abstinence rates (CAR)
0
{"evidence_spans": [{"end": 1613, "start": 1475, "text": "ESULTS:\r\nThe CARs for weeks 5\u201352 were 10.0 %, 12.4 %, and 15.3 % in the NRT, NRT+, and VR groups, respectively; no group differences were "}, {"end": 21731, "start": 21536, "text": "from the unadjusted and adjusted logistic regression models. The CARs for...
TITLE: Honey Mitigates Radiation-Induced Oral Mucositis in Head and Neck Cancer Patients without Affecting the Tumor Response ABSTRACT: Radiation-induced mucositis is a dose-limiting factor in the effective treatment of head and neck (H & N) cancers. The objective of this study was to understand the efficacy of h...
Intervention: honey mitigates Comparator: povidone-iodine Outcome: The onset of tolerable and intolerable mucositis
-1
{"evidence_spans": [{"end": 10228, "start": 10077, "text": "n a weekly basis in Figure 2. The onset of tolerable and intolerable mucositis was delayed in the patients using honey and was significant for week 2 ("}], "id": "2578", "pmcid": "5615289", "prompt_id": "2578", "split_group_id": "5615289", "votes": {"-1": 2}}
TITLE: Honey Mitigates Radiation-Induced Oral Mucositis in Head and Neck Cancer Patients without Affecting the Tumor Response ABSTRACT: Radiation-induced mucositis is a dose-limiting factor in the effective treatment of head and neck (H & N) cancers. The objective of this study was to understand the efficacy of h...
Intervention: honey mitigates Comparator: povidone-iodine Outcome: the incidence of grade 2 mucositis at week 2
-1
{"evidence_spans": [{"end": 10686, "start": 10516, "text": "grade 1 mucositis (p < 0.05). With continuation of the treatment, the incidence of grade 2 mucositis appeared only in the controls (32% (8/25) vs. 0% (0/25)) and was sign"}], "id": "2580", "pmcid": "5615289", "prompt_id": "2580", "split_group_id": "5615289", "...
TITLE: Honey Mitigates Radiation-Induced Oral Mucositis in Head and Neck Cancer Patients without Affecting the Tumor Response ABSTRACT: Radiation-induced mucositis is a dose-limiting factor in the effective treatment of head and neck (H & N) cancers. The objective of this study was to understand the efficacy of h...
Intervention: honey mitigates Comparator: povidone-iodine Outcome: The incidence of intolerable mucositis (only grade 3) at the end of week 7
0
{"evidence_spans": [{"end": 10926, "start": 10687, "text": "ficant (p = 0.002) at week 2. The incidence of intolerable mucositis (only grade 3) were seen earlier and at the end of week 3 in controls (16% (4/24), p = 0.03) and reached a peak in both the groups at the end of week 7 (12/24 in controls"}], "id": "2581", "p...
TITLE: Honey Mitigates Radiation-Induced Oral Mucositis in Head and Neck Cancer Patients without Affecting the Tumor Response ABSTRACT: Radiation-induced mucositis is a dose-limiting factor in the effective treatment of head and neck (H & N) cancers. The objective of this study was to understand the efficacy of h...
Intervention: honey mitigates Comparator: povidone-iodine Outcome: weight loss
-1
{"evidence_spans": [{"end": 11776, "start": 11577, "text": "as not significant (Table 2). Additionally, it was observed that when compared to the povidone-iodine (4.86 \u00b1 1.73) group, the weight loss was less in the honey cohorts (2.77 \u00b1 0.85) and was statisti"}], "id": "2582", "pmcid": "5615289", "prompt_id":...
TITLE: ABSTRACT.CONTEXT:: Denosumab 60 mg sc injection every 6 months for 36 months was well tolerated and effective in reducing the incidence of vertebral, nonvertebral, and hip fracture in predominantly Caucasian postmenopausal women with osteoporosis. ABSTRACT.OBJECTIVE:: The objective of this phase 3 fra...
Intervention: denosumab 60 mg sc every 6 months Comparator: placebo Outcome: the reduction in risk of 24-month incidence of new or worsening vertebral fracture
1
{"evidence_spans": [{"end": 1424, "start": 1194, "text": "\nABSTRACT.RESULTS::\r\nDenosumab significantly reduced the risk of new or worsening vertebral fracture by 65.7%, with incidences of 3.6% in denosumab and 10.3% in placebo at 24 months (hazard ratio 0.343; 95% confidence interval 0.1"}], "id": "2583", "pmcid": "...
TITLE: ABSTRACT.CONTEXT:: Denosumab 60 mg sc injection every 6 months for 36 months was well tolerated and effective in reducing the incidence of vertebral, nonvertebral, and hip fracture in predominantly Caucasian postmenopausal women with osteoporosis. ABSTRACT.OBJECTIVE:: The objective of this phase 3 fra...
Intervention: denosumab 60 mg sc every 6 months Comparator: placebo Outcome: Bone mineral density after 3 months at the lumbar spine, total hip, and femoral neck, and 6 months at the distal one third radius
1
{"evidence_spans": [{"end": 18792, "start": 18519, "text": "and P = .0344.\r\n\r\nBODY.RESULTS.BONE MINERAL DENSITY:\r\nMean BMD percentage change from baseline at 24 months was 9.1% and 0.1% at the lumbar spine in the denosumab and placebo groups, 4.6% and \u22121.1% at the total hip, 4.0% and \u22121.1% at the femora...
TITLE: ABSTRACT.CONTEXT:: Denosumab 60 mg sc injection every 6 months for 36 months was well tolerated and effective in reducing the incidence of vertebral, nonvertebral, and hip fracture in predominantly Caucasian postmenopausal women with osteoporosis. ABSTRACT.OBJECTIVE:: The objective of this phase 3 fra...
Intervention: denosumab 60 mg sc every 6 months Comparator: oral alendronate 35 mg weekly Outcome: Bone mineral density after 3 months at the lumbar spine, total hip, and femoral neck, at 12 and 24 months at the femoral neck, and from 18 months at the distal one third radius
1
{"evidence_spans": [{"end": 20458, "start": 19965, "text": "oral neck, and distal one third radius, respectively. As the referential comparison, the difference between the alendronate and placebo groups was significant as early as 3 months at the lumbar spine, total hip, and femoral neck (P < .01) and 6 months at the d...
TITLE: Bioelectrical impedance vector analysis for evaluating zinc supplementation in prepubertal and healthy children ABSTRACT.BACKGROUND: The prevalence of abnormal nutritional status has increased in children and adolescents. Nutritional assessment is important for monitoring the health and nutritional status....
Intervention: 10 mg Zn/day Comparator: sorbitol 10% Outcome: The body mass index-for-age
1
{"evidence_spans": [{"end": 1112, "start": 1022, "text": "T.RESULTS:\r\nThe body mass index-for-age increased after oral zinc supplementation in the E"}], "id": "2591", "pmcid": "4590407", "prompt_id": "2591", "split_group_id": "4590407", "votes": {"1": 2}}
TITLE: Bioelectrical impedance vector analysis for evaluating zinc supplementation in prepubertal and healthy children ABSTRACT.BACKGROUND: The prevalence of abnormal nutritional status has increased in children and adolescents. Nutritional assessment is important for monitoring the health and nutritional status....
Intervention: 10 mg Zn/day Comparator: baseline Outcome: The EG had increased in the soft tissue (primarily FFM)
1
{"evidence_spans": [{"end": 17968, "start": 17815, "text": " and the second measurement (after placebo or supplementation). The EG had increased in the soft tissue (primarily FFM) body composition after oral zinc "}], "id": "2592", "pmcid": "4590407", "prompt_id": "2592", "split_group_id": "4590407", "votes": {"1": 2}}
TITLE: Insulin Secretion and Its Determinants in the Progression of Impaired Glucose Tolerance to Type 2 Diabetes in Impaired Glucose-Tolerant Individuals ABSTRACT.OBJECTIVE: We investigated the effect of early-phase insulin secretion on the incidence of type 2 diabetes in individuals with impaired glucose tolera...
Intervention: lifestyle intervention Comparator: control Outcome: AIGR0–30 during the 4-year follow-up
0
{"evidence_spans": [{"end": 1192, "start": 1067, "text": "ESULTS:\r\nLifestyle intervention resulted in higher IS (P = 0.02) and lower unadjusted AIGR0\u201330 (P = 0.08) during the 4-year f"}], "id": "2596", "pmcid": "3263888", "prompt_id": "2596", "split_group_id": "3263888", "votes": {"0": 1}}
TITLE: THE EFFECT OF BODY AWARENESS THERAPY AND AEROBIC EXERCISES ON PAIN AND QUALITY OF LIFE IN THE PATIENTS WITH TENSION TYPE HEADACHE ABSTRACT.BACKGROUND:: This study is to investigate the effect of Body Awareness Therapy (BAT) and Aerobic Exercises on pain and quality of life in patients with Tension-Type Hea...
Intervention: Body Awareness Therapy (BAT) and aerobic exercise Comparator: baseline Outcome: Visual Analog Scale (VAS), Pain Disability Index (PDI) and Headache Impact Tests (HIT)
-1
{"evidence_spans": [{"end": 1077, "start": 901, "text": "SULTS::\r\nWhen the groups were compared at the end of the study, a significant decrease was observed in VAS, PDI and HIT values in the individuals in the BAT and aerobic exercis"}, {"end": 17203, "start": 17040, "text": " Therapy, AE: Aerobic Exercise While in...
TITLE: THE EFFECT OF BODY AWARENESS THERAPY AND AEROBIC EXERCISES ON PAIN AND QUALITY OF LIFE IN THE PATIENTS WITH TENSION TYPE HEADACHE ABSTRACT.BACKGROUND:: This study is to investigate the effect of Body Awareness Therapy (BAT) and Aerobic Exercises on pain and quality of life in patients with Tension-Type Hea...
Intervention: control Comparator: baseline Outcome: Visual Analog Scale (VAS), Pain Disability Index (PDI) and Headache Impact Tests (HIT)
0
{"evidence_spans": [{"end": 17276, "start": 17040, "text": " Therapy, AE: Aerobic Exercise While in individuals in BAT group and in aerobic exercise group, there was a difference found in VAS, PDI and HIT values prior to and after the treatment (p<0.05); in individuals in control group, there "}], "id": "2603", "pmci...
TITLE: THE EFFECT OF BODY AWARENESS THERAPY AND AEROBIC EXERCISES ON PAIN AND QUALITY OF LIFE IN THE PATIENTS WITH TENSION TYPE HEADACHE ABSTRACT.BACKGROUND:: This study is to investigate the effect of Body Awareness Therapy (BAT) and Aerobic Exercises on pain and quality of life in patients with Tension-Type Hea...
Intervention: aerobic exercise Comparator: control Outcome: VT: Vitality
1
{"evidence_spans": [{"end": 20273, "start": 19989, "text": "prior to the treatment (p>0.05). As for after the treatment, there was a difference found among the groups concerning RP and VT values (p<0.05). RP values in BAT group and in aerobic exercise group were found to be significantly high, VT values in aerobic exer...
TITLE: THE EFFECT OF BODY AWARENESS THERAPY AND AEROBIC EXERCISES ON PAIN AND QUALITY OF LIFE IN THE PATIENTS WITH TENSION TYPE HEADACHE ABSTRACT.BACKGROUND:: This study is to investigate the effect of Body Awareness Therapy (BAT) and Aerobic Exercises on pain and quality of life in patients with Tension-Type Hea...
Intervention: aerobic exercise Comparator: baseline Outcome: VT: Vitality
1
{"evidence_spans": [{"end": 20500, "start": 20274, "text": "be significantly high (Table 4). When the differentials of PF, RP, BP, GH, VT, SF, RE, MH, PCS, MCS among the groups prior to and after the treatment were taken, only the VT differential was found to be different for aerobic e"}], "id": "2609", "pmcid": "54464...
TITLE: Effect of a combination of genistein, polyunsaturated fatty acids and vitamins D3 and K1 on bone mineral density in postmenopausal women: a randomized, placebo-controlled, double-blind pilot study ABSTRACT.PURPOSE: Many postmenopausal women desire non-pharmaceutical alternatives to hormone therapy for prot...
Intervention: placebo Comparator: baseline Outcome: bone mineral density (BMD) At the 6-month time point
-1
{"evidence_spans": [{"end": 23491, "start": 23245, "text": "terol: <200 mg/mL\r\n\r\nBODY.RESULTS.BONE MINERAL DENSITY:\r\nAt the 6-month time point, subjects supplemented with the GBB (n = 30) maintained femoral neck BMD, whereas in the placebo group (n = 28), BMD significantly decreased (p = 0.007, Fig. 2a), "}], "id...
TITLE: Effect of a combination of genistein, polyunsaturated fatty acids and vitamins D3 and K1 on bone mineral density in postmenopausal women: a randomized, placebo-controlled, double-blind pilot study ABSTRACT.PURPOSE: Many postmenopausal women desire non-pharmaceutical alternatives to hormone therapy for prot...
Intervention: calcium only or the geniVidaTM bone blend (GBB) Comparator: baseline Outcome: Endometrial Thickness
-1
{"evidence_spans": [{"end": 30188, "start": 30080, "text": "e point did endometrial thickness (ET) differ between the groups. However, ET significantly decreased in the"}], "id": "2612", "pmcid": "3549413", "prompt_id": "2612", "split_group_id": "3549413", "votes": {"-1": 1}}
TITLE: Efficacy and Safety of a Traditional Herbal Medicine, ABSTRACT: Hochu-ekki-to is a traditional herbal (Kampo) medicine that has been shown to be effective for patients with Kikyo (delicate, easily fatigable, or hypersensitive) constitution. Previous case reports have suggested that this herbal drug was ef...
Intervention: Hochu-ekki-to Comparator: placebo Outcome: The prominent efficacy rate
0
{"evidence_spans": [{"end": 16090, "start": 15891, "text": "ore became 0 at the end of the study. The prominent efficacy rate was indeed moderately higher in the Hochu-ekki-to group (19%; 7 of 37) than in the placebo group (5%; 2 of 40), although there was no"}], "id": "2615", "pmcid": "2887326", "prompt_id": "2615", "...
TITLE: Efficacy and Safety of a Traditional Herbal Medicine, ABSTRACT: Hochu-ekki-to is a traditional herbal (Kampo) medicine that has been shown to be effective for patients with Kikyo (delicate, easily fatigable, or hypersensitive) constitution. Previous case reports have suggested that this herbal drug was ef...
Intervention: Hochu-ekki-to Comparator: placebo Outcome: the aggravated rate, defined as ratio of patients whose TEA had increased more than 50% at 24 weeks from the beginning of the study
-1
{"evidence_spans": [{"end": 1839, "start": 1702, "text": "). The aggravated rate was significantly (P < 0.05) lower in the Hochu-ekki-to group (3%; 1 of 37) than in the placebo group (18%; 7 of 3"}, {"end": 16354, "start": 16091, "text": " a significant difference (P = 0.06). Furthermore, the aggravated rate, defined a...
TITLE: Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studies ABSTRACT: BODY: Intravenous (i.v.) bisphosphonates are the standard of care for patients with metastatic bone disease, w...
Intervention: oral ibandronate 50 mg Comparator: placebo Outcome: bone events requiring surgery
0
{"evidence_spans": [], "id": "2619", "pmcid": "2409647", "prompt_id": "2619", "split_group_id": "2409647", "votes": {"0": 1}}
TITLE: Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studies ABSTRACT: BODY: Intravenous (i.v.) bisphosphonates are the standard of care for patients with metastatic bone disease, w...
Intervention: oral ibandronate 50 mg Comparator: placebo Outcome: the number of skeletal fractures
0
{"evidence_spans": [{"end": 10506, "start": 10385, "text": "rgery (P=0.037) (Figure 1). There was no significant difference in the number of skeletal fractures with ibandronate comp"}], "id": "2620", "pmcid": "2409647", "prompt_id": "2620", "split_group_id": "2409647", "votes": {"0": 1}}
TITLE: Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studies ABSTRACT: BODY: Intravenous (i.v.) bisphosphonates are the standard of care for patients with metastatic bone disease, w...
Intervention: oral ibandronate 50 mg Comparator: placebo Outcome: the mean number of measurement periods with events per patient
-1
{"evidence_spans": [{"end": 11464, "start": 11190, "text": "se comparisons vs placebo.). Supportive analyses of new bone events demonstrated that the mean number of events and the mean number of measurement periods with events per patient were significantly reduced in the ibandronate group compared with placebo (P=0.00...
TITLE: Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studies ABSTRACT: BODY: Intravenous (i.v.) bisphosphonates are the standard of care for patients with metastatic bone disease, w...
Intervention: oral ibandronate 50 mg Comparator: placebo Outcome: the bone marker urinary CTx over the 96-week study period
-1
{"evidence_spans": [{"end": 12379, "start": 12150, "text": " for ibandronate vs placebo. Patients receiving oral ibandronate 50 mg showed a significant decrease from baseline in the bone marker urinary CTx over the 96-week study period compared with placebo (median change \u221277.3% and +11."}], "id": "2623", "pmcid"...
TITLE: Efficacy of a Web-Based Guided Recommendation Service for a Curated List of Readily Available Mental Health and Well-Being Mobile Apps for Young People: Randomized Controlled Trial ABSTRACT.BACKGROUND: Mental disorders are highly prevalent for the people who are aged between 16 and 25 years and can permane...
Intervention: Web-based self-guided app recommendation service ("The Toolbox�) Comparator: control group Outcome: well-being at 4 weeks
0
{"evidence_spans": [{"end": 2382, "start": 2232, "text": " the trial. Results demonstrated no significant effect of \"The Toolbox\" intervention on participant well-being at 4 weeks compared with the control gr"}, {"end": 2383, "start": 2232, "text": " the trial. Results demonstrated no significant effect of \"The Tool...
TITLE: Efficacy of a Web-Based Guided Recommendation Service for a Curated List of Readily Available Mental Health and Well-Being Mobile Apps for Young People: Randomized Controlled Trial ABSTRACT.BACKGROUND: Mental disorders are highly prevalent for the people who are aged between 16 and 25 years and can permane...
Intervention: Web-based self-guided app recommendation service ("The Toolbox�) Comparator: control group Outcome: Subscales of Mental Health Continuum-Short Form (MHC-SF)
0
{"evidence_spans": [{"end": 2575, "start": 2383, "text": "up (P=.66). There were also no significant differences between the intervention and control groups at 4 weeks on any of the subscales of the MHC-SF (psychological: P=.95, social: P=.42, emotio"}, {"end": 29733, "start": 29505, "text": "ESULTS.SUBSCALES OF MENTAL...
TITLE: Efficacy of a Web-Based Guided Recommendation Service for a Curated List of Readily Available Mental Health and Well-Being Mobile Apps for Young People: Randomized Controlled Trial ABSTRACT.BACKGROUND: Mental disorders are highly prevalent for the people who are aged between 16 and 25 years and can permane...
Intervention: Web-based self-guided app recommendation service ("The Toolbox�) Comparator: control group Outcome: mood, energy, rest, and sleep
1
{"evidence_spans": [{"end": 2769, "start": 2576, "text": "al: P=.95). Repeat engagement with the study platform resulted in a significant difference in mood, energy, rest, and sleep trajectories between intervention and control groups as measured by E"}], "id": "2626", "pmcid": "5446666", "prompt_id": "2626", "split_gr...
TITLE: Reduction of Nasal Bone Fracture using Ultrasound Imaging during Surgery ABSTRACT.BACKGROUND: Most nasal bone fractures are corrected using non-invasive methods. Often, patients are dissatisfied with surgical outcomes following such closed approach. In this study, we compare surgical outcomes following bli...
Intervention: ultrasound-guided reduction Plane II fracture Comparator: control group (blind reduction) Plane II fracture Outcome: level of patients dissatisfaction
-1
{"evidence_spans": [{"end": 1663, "start": 1493, "text": "=0.007). Likewise, among the Plane II fracture patients, those who underwent ultrasound-guided reduction were less dissatisfied than those who underwent blind reduction ("}], "id": "2629", "pmcid": "5556716", "prompt_id": "2629", "split_group_id": "5556716", "vo...
TITLE: Efficacy of local drug delivery of ABSTRACT.CONTEXT:: Periodontitis is an inflammatory disease of microbial origin. Locally delivered antimicrobials reduce subgingival flora. Achyranthes aspera gel has antimicrobial, antioxidant, anti-inflammatory, and immunostimulant effects. ABSTRACT.AIMS:: To evalu...
Intervention: Group A: scaling and root planing (SRP) with A. aspera gel Comparator: Group B: SRP with placebo gel Outcome: probing depth (PD)
-1
{"evidence_spans": [{"end": 7818, "start": 7616, "text": "ally significant results (P < 0.001). The mean PDs in the test and control groups at baseline were 5.16 and 4.44, respectively, and after 3 months were 2.92 and 4.10, respectively, which showed statisti"}], "id": "2631", "pmcid": "5767990", "prompt_id": "2631", ...
TITLE: Efficacy of local drug delivery of ABSTRACT.CONTEXT:: Periodontitis is an inflammatory disease of microbial origin. Locally delivered antimicrobials reduce subgingival flora. Achyranthes aspera gel has antimicrobial, antioxidant, anti-inflammatory, and immunostimulant effects. ABSTRACT.AIMS:: To evalu...
Intervention: Group A: scaling and root planing (SRP) with A. aspera gel Comparator: Group B: SRP with placebo gel Outcome: The mean GI after 3 months
-1
{"evidence_spans": [{"end": 7615, "start": 7413, "text": "reduction from baseline to 3 months. The mean GIs in the test and control groups at baseline were 2.60 and 2.57, respectively, and after 3 months were 1.35 and 2.32, respectively, which showed statisti"}, {"end": 8328, "start": 8034, "text": "icant results (P <...
TITLE: Effects of Vitamin D Intake on FEV1 and COPD Exacerbation: A Randomized Clinical Trial Study ABSTRACT.AIM:: This study aimed to evaluate the effects of vitamin D intake on COPD exacerbation and FEV1 in the patients with severe and very severe COPD. ABSTRACT.METHODS:: This double blind placebo control r...
Intervention: 100,000 IU of oral vitamin D per month, for 6 months Comparator: placebo Outcome: Forced Expiratory Volume in the first second (FEV1)
1
{"evidence_spans": [{"end": 9217, "start": 9080, "text": "placebo group patients. Also, after the study, in the study group, FEV1 was increased and the number of COPD exacerbations was decreased "}, {"end": 9393, "start": 9362, "text": " 34.6\u00b18.5 34.4\u00b19.2 0.89 After 5"}], "id": "2634", "pmcid": "4802087", "pr...
TITLE: Stenting versus aggressive medical therapy for intracranial arterial stenosis: more harm than good ABSTRACT.EXPANDED ABSTRACT.CITATION: Chimowitz MI, Lynn MJ, Derdeyn CP, Turan TN, Fiorella D, Lane BF, Janis LS, Lutsep HL, Barnwell SL, Waters MF, Hoh BL, Hourihane JM, Levy EI, Alexandrov AV, Harrigan MR, C...
Intervention: percutaneous transluminal angioplasty and stenting (PTAS) Comparator: medical-management group Outcome: The 30-day rate of stroke or death
1
{"evidence_spans": [{"end": 2488, "start": 2271, "text": "PTAS group. The 30-day rate of stroke or death was 14.7% in the PTAS group (nonfatal stroke, 12.5%; fatal stroke, 2.2%) and 5.8% in the medical-management group (nonfatal stroke, 5.3%; non-stroke-related death, 0.4%) "}], "id": "2636", "pmcid": "3580611", "promp...
TITLE: Treatment of Postoperative Pain in Pediatric Operations: Comparing the Efficiency of Bupivacaine, Bupivacaine-Dexmedetomidine and Bupivacaine-Fentanyl for Caudal Block ABSTRACT.BACKGROUND: Caudal analgesia is a common method for postoperative pain management in pediatric patients. Additive agents such as o...
Intervention: the bupivacaine-dexmedetomidine group (Group BD) received 0.25% bupivacaine (1 mL/kg) plus 2 μg/kg dexmedetomidine Comparator: the bupivacaine-fentanyl group (Group BF) received 0.25% bupivacaine (1 mL/kg) plus 2 μg/kg fentanyl and the bupivacaine group (Group B) received 0.25% bupivacaine (1 ml/kg) Outco...
1
{"evidence_spans": [{"end": 1830, "start": 1722, "text": "P < 0.001). The sedation scores were higher in the BD group than in the other two groups at all time points "}, {"end": 12555, "start": 12346, "text": " \u2264 0.049) and group BD and BF (< 0.001 \u2264 P \u2264 0.034). The lowest scores were observed in group B...
TITLE: Treatment of Postoperative Pain in Pediatric Operations: Comparing the Efficiency of Bupivacaine, Bupivacaine-Dexmedetomidine and Bupivacaine-Fentanyl for Caudal Block ABSTRACT.BACKGROUND: Caudal analgesia is a common method for postoperative pain management in pediatric patients. Additive agents such as o...
Intervention: the bupivacaine-dexmedetomidine group (Group BD) received 0.25% bupivacaine (1 mL/kg) plus 2 μg/kg dexmedetomidine Comparator: the bupivacaine-fentanyl group (Group BF) received 0.25% bupivacaine (1 mL/kg) plus 2 μg/kg fentanyl and the bupivacaine group (Group B) received 0.25% bupivacaine (1 ml/kg) Outc...
-1
{"evidence_spans": [{"end": 11515, "start": 11319, "text": " < 0.001) and between group B and BF (P < 0.001). The lowest mean scores were observed in the BD group. In the 1st, 2nd and 4th h after the operation, the mean pain scores were significantly lower"}], "id": "2642", "pmcid": "5101645", "prompt_id": "2642", "spl...
TITLE: Antihistamines in the treatment of pruritus in psoriasis ABSTRACT.AIM: To evaluate the efficacy of antihistamines in reducing pruritus in psoriasis, 61 patients were randomized to be treated for 1 week with clemastine (n = 20), levocetirizine (n = 21) or placebo (n = 20). ABSTRACT.MATERIAL AND METHODS: ...
Intervention: 1 week with clemastine and levocetirizine Comparator: placebo Outcome: the mean intensity of pruritus
-1
{"evidence_spans": [{"end": 10880, "start": 10728, "text": " in the placebo group (p = 0.07). A statistically significant decrease in mean VAS scoring was observed in clemastine and levocetirizine groups (p < 0.0"}], "id": "2643", "pmcid": "5831281", "prompt_id": "2643", "split_group_id": "5831281", "votes": {"-1": 1}}
TITLE: The Effect of Midazolam on Decreasing the Duration of Intussusception Hydrostatic Reduction in Children ABSTRACT.BACKGROUND AND OBJECTIVE:: The use of sedative medications may be effective in the success and facilitation of the intussusception non-surgical treatment. Therefore, the purpose of this study wa...
Intervention: Midazolam at the concentration of 1.0 mg/kg (up to 3 mg) was infused, and then barium reduction was performed under fluoroscopy guideline Comparator: placebo Outcome: reduction in intussusception
0
{"evidence_spans": [{"end": 1240, "start": 1049, "text": "SULTS::\r\nOf 16 patients that received Midazolam, 15 patients demonstrated successful reduction; and of 16 patients that received distilled water, only 11 patients showed successful reduction "}], "id": "2647", "pmcid": "4639339", "prompt_id": "2647", "split_gr...
TITLE: Prevention of Type 2 Diabetes in Subjects With Prediabetes and Metabolic Syndrome Treated With Phentermine and Topiramate Extended Release ABSTRACT.OBJECTIVE: To evaluate over 108 weeks the effect of phentermine and topiramate extended release (PHEN/TPM ER) treatment on progression to type 2 diabetes and/o...
Intervention: intent-to-treat population using multiple imputation (ITT-MI) of subjects with prediabetes and/or MetS Comparator: placebo Outcome: incidence rate of type 2 diabetes
-1
{"evidence_spans": [{"end": 1495, "start": 1110, "text": "or MetS. After 108 weeks, subjects with prediabetes and/or MetS in the placebo, 7.5/46, and 15/92 groups experienced mean percent weight loss of 2.5, 10.9, and 12.1%, respectively (ITT-MI; P < 0.0001 vs. placebo), associated with reductions of 70.5 and 78.7% in ...
TITLE: Effect of a Mindfulness Training Program on the Impulsivity and Aggression Levels of Adolescents with Behavioral Problems in the Classroom ABSTRACT: Objective: The aim of the present study was to analyze the effects of a mindfulness training psycho-educative program on impulsivity and aggression levels in ...
Intervention: mindfulness training psycho-educative program Comparator: decrease in the levels of impulsivity and aggressiveness in control grup Outcome: decrease in the levels of impulsivity and aggressiveness in experimental group
1
{"evidence_spans": [{"end": 794, "start": 638, "text": "s: Statistical analyses showed a significant decrease in the levels of impulsivity and aggressiveness in the experimental group compared with the control gr"}, {"end": 795, "start": 638, "text": "s: Statistical analyses showed a significant decrease in the levels ...
TITLE: Effectiveness of trigger point dry needling for plantar heel pain: a randomized controlled trial ABSTRACT: BODY.BACKGROUND: Plantar heel pain (plantar fasciitis) can be managed with myofascial trigger point dry needling of myofascial trigger points, however there is only poor quality evidence supporti...
Intervention: real trigger point dry needling Comparator: sham trigger point dry needling Outcome: Relief of plantar pain
1
{"evidence_spans": [{"end": 1200, "start": 978, "text": " end-point, significant effects favored real dry needling over sham dry needling for pain (adjusted mean difference: VAS first-step pain -14.4 mm, 95% CI -23.5 to -5.2, p=0.002; FHSQ foot pain 10.0 points, 95% CI 1.0 to 19"}], "id": "2318", "pmcid": "3668955", "p...
TITLE: After the diabetes care trial ends, now what? A 1-year follow-up of the RxING study ABSTRACT.INTRODUCTION: There is strong evidence that pharmacist care improves patients' glycaemic control. However, the sustainability and durability of such interventions beyond the research period is not known. RxING was ...
Intervention: RxING study first six month Comparator: A 1-year follow-up of the RxING study Outcome: Increase of glycaemic control.
1
{"evidence_spans": [{"end": 7979, "start": 7671, "text": "% CI \u221213.3 to 0.88, p=0.085). In the RxING study, HbA1c was reduced from 9.1% (SD 1) at baseline to 7.3% (SD 0.9) at 26 weeks, a change of 1.8% (95% CI 1.4 to 2, p<0.001). Twelve months after completing the study, HbA1c increased from 7.3% (SD 0.9) at stud...
TITLE: After the diabetes care trial ends, now what? A 1-year follow-up of the RxING study ABSTRACT.INTRODUCTION: There is strong evidence that pharmacist care improves patients' glycaemic control. However, the sustainability and durability of such interventions beyond the research period is not known. RxING was ...
Intervention: RxING study first six month Comparator: base line Outcome: reduced cardiovascular risk.
-1
{"evidence_spans": [{"end": 8367, "start": 8144, "text": "n of the intervention period. Patients' risk of cardiovascular events in the next 10 years was reduced from 31% (SD 17.3) at baseline to 26.7% (SD 14.5) at study end, an absolute reduction of 4.3% (a 14% relative reduction"}, {"end": 8367, "start": 8154, "text"...
TITLE: Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial ABSTRACT.BACKGROUND:: Mobility impairment is a common disability in MS and negatively impacts patients' lives. ABSTRACT.OBJECTIVE:: Evaluate the effect of prolonged-release (PR) fampridine (extended-release d...
Intervention: Prolonged-release fampridine Comparator: Placebo Outcome: Improvement in the 12-item MS Walking Scale (MSWS-12) Score during 24 weeks
1
{"evidence_spans": [{"end": 1092, "start": 939, "text": " countries. PR-fampridine therapy resulted in greater median improvements from baseline in MSWS-12 score, TUG speed and BBS total score versus placebo ov"}, {"end": 1360, "start": 1093, "text": "r 24 weeks. A higher proportion of patients receiving PR-fampridine ...
TITLE: Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial ABSTRACT.BACKGROUND:: Mobility impairment is a common disability in MS and negatively impacts patients' lives. ABSTRACT.OBJECTIVE:: Evaluate the effect of prolonged-release (PR) fampridine (extended-release d...
Intervention: Prolonged-release fampridine Comparator: Placebo Outcome: Improvement in Timed Up and Go (TUG) speed during 24 weeks
1
{"evidence_spans": [{"end": 1092, "start": 939, "text": " countries. PR-fampridine therapy resulted in greater median improvements from baseline in MSWS-12 score, TUG speed and BBS total score versus placebo ov"}], "id": "2339", "pmcid": "4749757", "prompt_id": "2339", "split_group_id": "4749757", "votes": {"1": 2}}
TITLE: Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial ABSTRACT.BACKGROUND:: Mobility impairment is a common disability in MS and negatively impacts patients' lives. ABSTRACT.OBJECTIVE:: Evaluate the effect of prolonged-release (PR) fampridine (extended-release d...
Intervention: Prolonged-release fampridine Comparator: Placebo Outcome: Improvement in Berg Balance Scale (BBS) Score during 24 weeks
1
{"evidence_spans": [{"end": 1092, "start": 880, "text": ".RESULTS::\r\n132 patients were randomised at 24 sites in six countries. PR-fampridine therapy resulted in greater median improvements from baseline in MSWS-12 score, TUG speed and BBS total score versus placebo ov"}, {"end": 1092, "start": 939, "text": " countri...
TITLE: Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial ABSTRACT.BACKGROUND:: Mobility impairment is a common disability in MS and negatively impacts patients' lives. ABSTRACT.OBJECTIVE:: Evaluate the effect of prolonged-release (PR) fampridine (extended-release d...
Intervention: Prolonged-release fampridine Comparator: Placebo Outcome: Adverse Events
0
{"evidence_spans": [{"end": 19684, "start": 19543, "text": "lity index was 0.00 (\u20130.04, 0.04). The proportion of patients with any AE was similar in placebo-treated patients (49 (77%)) versus patients"}], "id": "2341", "pmcid": "4749757", "prompt_id": "2341", "split_group_id": "4749757", "votes": {"0": 2}}
TITLE: Psycho-Biological Changes with Add on Yoga Nidra in Patients with Menstrual Disorders: a Randomized Clinical Trial ABSTRACT: Introduction: Menstrual disorders are common problems among women in the reproductive age group. Yuga interventions may decrease the physical and psychological problems related ...
Intervention: Yogic intervention and medication Comparator: Prescribed medication without yogic intervention Outcome: General health
1
{"evidence_spans": [{"end": 14213, "start": 13945, "text": "ut there was no significant\r\ndifferences in control group (P>0.05) (Table\r\n2). Table 3 and 4 depicts comparison of mean differences in PGWBI scores and hormonal\r\nprofile. Significant improvement in domains of anxiety (P<0.01), depression\r\n(P<0.02), p...
TITLE: Dermoscopic Changes of Melanocytic Nevi after Psoralen-Ultraviolet A and Narrow-Band Ultraviolet B Phototherapy ABSTRACT.BACKGROUND:: Phototherapy may alter the morphologic features of melanocytic nevi. Dermoscopy is a non-invasive method for evaluation of skin lesions, specifically melanocytic nevi. AB...
Intervention: All uncovered nevi Comparator: All covered nevi Outcome: Demoscopic changes
1
{"evidence_spans": [{"end": 1033, "start": 890, "text": ".RESULTS::\r\nOverall demoscopic changes were observed in 34/37 (91.8%) of the uncovered nevi compared to 16/37 (43.2%) of the covered nevi (P va"}], "id": "2363", "pmcid": "4763632", "prompt_id": "2363", "split_group_id": "4763632", "votes": {"1": 2}}
TITLE: Dermoscopic Changes of Melanocytic Nevi after Psoralen-Ultraviolet A and Narrow-Band Ultraviolet B Phototherapy ABSTRACT.BACKGROUND:: Phototherapy may alter the morphologic features of melanocytic nevi. Dermoscopy is a non-invasive method for evaluation of skin lesions, specifically melanocytic nevi. AB...
Intervention: Psoralen-ultraviolet A (PUVA) Comparator: Narrowband ultraviolet B (NB-UVB) Outcome: Demoscopic changes
1
{"evidence_spans": [{"end": 1330, "start": 1175, "text": "on (18.8%). Compared to NB-UVB, dermoscopic changes were more frequent in both covered and uncovered nevi of the PUVA group. (P values 0.041 and 0.0172, re"}, {"end": 9183, "start": 9038, "text": "B phototherapy were compared. The prevalence of overall dermoscop...
TITLE: Dermoscopic Changes of Melanocytic Nevi after Psoralen-Ultraviolet A and Narrow-Band Ultraviolet B Phototherapy ABSTRACT.BACKGROUND:: Phototherapy may alter the morphologic features of melanocytic nevi. Dermoscopy is a non-invasive method for evaluation of skin lesions, specifically melanocytic nevi. AB...
Intervention: Psoralen-ultraviolet A (PUVA) Comparator: Narrowband ultraviolet B (NB-UVB) Outcome: Formation of new dot-globule
1
{"evidence_spans": [{"end": 1434, "start": 1331, "text": "pectively). New dot/globule formation was observed more frequently in the covered and uncovered nevi of"}, {"end": 9479, "start": 9349, "text": "f hyperpigmentation. However, new dot-globule formation was noted in all nevi (100%) exposed to PUVA compared to only...
TITLE: Hyperbaric treatment for children with autism: a multicenter, randomized, double-blind, controlled trial ABSTRACT.BACKGROUND: Several uncontrolled studies of hyperbaric treatment in children with autism have reported clinical improvements; however, this treatment has not been evaluated to date with a contr...
Intervention: 40 hourly treatments of either hyperbaric treatment Comparator: control group Outcome: mean physician Clinical Global Impression (CGI) scale - eye contact
1
{"evidence_spans": [{"end": 1462, "start": 979, "text": "ESULTS:\r\nAfter 40 sessions, mean physician CGI scores significantly improved in the treatment group compared to controls in overall functioning (p = 0.0008), receptive language (p < 0.0001), social interaction (p = 0.0473), and eye contact (p = 0.0102); 9/30 ch...
TITLE: Hyperbaric treatment for children with autism: a multicenter, randomized, double-blind, controlled trial ABSTRACT.BACKGROUND: Several uncontrolled studies of hyperbaric treatment in children with autism have reported clinical improvements; however, this treatment has not been evaluated to date with a contr...
Intervention: 40 hourly treatments of either hyperbaric treatment Comparator: control group Outcome: Mean parental CGI scores - overall functioning
1
{"evidence_spans": [{"end": 1654, "start": 1463, "text": "0.0024). Mean parental CGI scores significantly improved in the treatment group compared to controls in overall functioning (p = 0.0336), receptive language (p = 0.0168), and eye contact (p ="}], "id": "2386", "pmcid": "2662857", "prompt_id": "2386", "split_grou...
TITLE: Comparing McGRATH® MAC, C-MAC®, and Macintosh Laryngoscopes Operated by Medical Students: A Randomized, Crossover, Manikin Study ABSTRACT: We hypothesized that the McGRATH MAC would decrease the time of intubation compared to C-MAC for novices. Thirty-nine medical students who had used the Macintosh blade ...
Intervention: McGRATH MAC and C-MAC Comparator: Macintosh blade Outcome: success rate of intubation on the first, second, and third attempts
1
{"evidence_spans": [{"end": 11112, "start": 10830, "text": " and P = 0.017, resp.). The success rate of intubation on the first, second, and third attempts increased significantly with the McGRATH MAC and C-MAC compared to the Macintosh blade in the normal airway (P < 0.001 on the first attempt, P < 0.001 on the second...
TITLE: Ketamine perturbs perception of the flow of time in healthy volunteers ABSTRACT.RATIONALE: Disturbances in the subjective experience of time have been observed both in schizophrenia and following acute administration of ketamine. However, effects of ketamine on more objective timing tasks have not yet been...
Intervention: ketamine (100 ng/ml blood plasma level) Comparator: placebo Outcome: accuracy in the timing task
-1
{"evidence_spans": [{"end": 1163, "start": 1021, "text": " Scales. Critically, ketamine also impaired accuracy on the perceptual timing task while having no effect on performance of the colour percept"}, {"end": 21136, "start": 20891, "text": "n treatment and task [F(1, 10) = 8.73, p < 0.05]. Post-hoc analysis with pai...
TITLE: Experience of unpleasant sensations in the mouth after injection of saline from prefilled syringes ABSTRACT.BACKGROUND: Nurses at The Norwegian Radium Hospital have reported that some patients notice an unpleasant smell or taste in accordance with flushing of intravenous lines with commercially available p...
Intervention: saline 9 mg/ml syringes Comparator: saline 9 mg/ml for injection in polyethylene package Outcome: The intensity of an unpleasant sensation
1
{"evidence_spans": [{"end": 1293, "start": 1121, "text": "yringes. The intensity of the unpleasant sensation was rated significantly higher after injection of saline from prefilled syringes compared to saline from polyethylene (p "}, {"end": 7808, "start": 7624, "text": " used the word plastic. The intensity of an unpl...
TITLE: Does short-term whole-body vibration training affect arterial stiffness in chronic stroke? A preliminary study ABSTRACT: [Purpose] Previous studies have shown that stroke is associated with increased arterial stiffness that can be diminished by a program of physical activity. A novel exercise interventi...
Intervention: WBV training Comparator: control group Outcome: compliance coefficient (CC)
0
{"evidence_spans": [{"end": 19523, "start": 19352, "text": "ction effect was not significant (p = 0.166). For the distensibility coefficient\r\n(DC) (Table 2) there was no significant\r\ninteraction effect (p = 0.124) or main effect be"}], "id": "2414", "pmcid": "4842481", "prompt_id": "2414", "split_group_id": "484248...
TITLE: Randomized, Double-Blinded, Phase 2 Trial of WR 279,396 (Paromomycin and Gentamicin) for Cutaneous Leishmaniasis in Panama ABSTRACT: In this randomized, double-blinded Phase 2 trial, 30 patients with Leishmania panamensis cutaneous leishmaniasis were randomly allocated (1:1) to receive once daily topical t...
Intervention: Paromomycin Alone (15% paromomycin) for 20 days Comparator: WR 279,396 (15% paromomycin + 0.5% gentamicin) Outcome: index lesion cure rate after 6 months follow-up
0
{"evidence_spans": [{"end": 568, "start": 430, "text": "s. The index lesion cure rate after 6 months follow-up was 13 of 15 (87%) for WR 279,396 and 9 of 15 (60%) for Paromomycin Alone (P = 0.09"}], "id": "2418", "pmcid": "3771300", "prompt_id": "2418", "split_group_id": "3771300", "votes": {"0": 1}}
TITLE: Hormone-Balancing Effect of Pre-Gelatinized Organic Maca (Lepidium peruvianum Chacon): (II) Physiological and Symptomatic Responses of Early-Postmenopausal Women to Standardized doses of Maca in Double Blind, Randomized, Placebo-Controlled, Multi-Centre Clinical Study ABSTRACT: This was a double-blind, ran...
Intervention: Pre-Gelatinized Organic Maca (Maca-GO) treatment Comparator: Placebo Outcome: Follicle Stimulating Hormone (FSH) level in group APMM
-1
{"evidence_spans": [{"end": 1667, "start": 1527, "text": "y. Maca-GO significantly stimulated production of E2 (P<0.001) with a simultaneous suppression (P<0.05) of blood FSH, increase (P<0.05) in H"}, {"end": 21428, "start": 21087, "text": " and AMMPM).\r\n\r\nBODY.RESULTS.TRIAL I:\r\nResults from hormone assays (Tabl...
TITLE: Hormone-Balancing Effect of Pre-Gelatinized Organic Maca (Lepidium peruvianum Chacon): (II) Physiological and Symptomatic Responses of Early-Postmenopausal Women to Standardized doses of Maca in Double Blind, Randomized, Placebo-Controlled, Multi-Centre Clinical Study ABSTRACT: This was a double-blind, ran...
Intervention: Pre-Gelatinized Organic Maca (Maca-GO) treatment Comparator: Placebo Outcome: estradiol (E2) level in group APMM
1
{"evidence_spans": [{"end": 1667, "start": 1527, "text": "y. Maca-GO significantly stimulated production of E2 (P<0.001) with a simultaneous suppression (P<0.05) of blood FSH, increase (P<0.05) in H"}, {"end": 21428, "start": 21087, "text": " and AMMPM).\r\n\r\nBODY.RESULTS.TRIAL I:\r\nResults from hormone assays (Tabl...
TITLE: Hormone-Balancing Effect of Pre-Gelatinized Organic Maca (Lepidium peruvianum Chacon): (II) Physiological and Symptomatic Responses of Early-Postmenopausal Women to Standardized doses of Maca in Double Blind, Randomized, Placebo-Controlled, Multi-Centre Clinical Study ABSTRACT: This was a double-blind, ran...
Intervention: Pre-Gelatinized Organic Maca (Maca-GO) treatment Comparator: Placebo Outcome: severity of individual menopausal symptoms (hot flushes and night sweating in particular)
-1
{"evidence_spans": [{"end": 2121, "start": 1668, "text": "L. Maca-GO significantly reduced both frequency and severity of individual menopausal symptoms (hot flushes and night sweating in particular) resulting in significant (P<0.001) alleviation of KMI (from 22 to 10), thus, offering an attractive non-hormonal additio...
TITLE: A randomized prospective controlled trial comparing the laryngeal tube suction disposable and the supreme laryngeal mask airway: the influence of head and neck position on oropharyngeal seal pressure ABSTRACT.BACKGROUND: The Laryngeal Tube Suction Disposable (LTS-D) and the Supreme Laryngeal Mask Airway (S...
Intervention: The Laryngeal Tube Suction Disposable (LTS-D) Comparator: the Supreme Laryngeal Mask Airway (SLMA) Outcome: successfull insertion
0
{"evidence_spans": [{"end": 14220, "start": 13976, "text": "between the groups, Table 1. LTS-D and the SLMA were inserted successfully in all patients requiring one attempt in 87.5 and 86.2 % of patients for SLMA and LTS-D respectively and a second attempt in 12.5 and 13.8 % of patients for SLMA and LTS"}], "id": "2431...
TITLE: A randomized prospective controlled trial comparing the laryngeal tube suction disposable and the supreme laryngeal mask airway: the influence of head and neck position on oropharyngeal seal pressure ABSTRACT.BACKGROUND: The Laryngeal Tube Suction Disposable (LTS-D) and the Supreme Laryngeal Mask Airway (S...
Intervention: the Supreme Laryngeal Mask Airway (SLMA) Comparator: The Laryngeal Tube Suction Disposable (LTS-D) Outcome: The mean peak inspiratory pressure and plateau pressure
-1
{"evidence_spans": [{"end": 17002, "start": 16844, "text": "ificantly lower with head/neck extension. (0.0038). The mean peak inspiratory pressure and plateau pressure in patients with SLMA was significantly lower tha"}], "id": "2434", "pmcid": "5054611", "prompt_id": "2434", "split_group_id": "5054611", "votes": {"-1...
TITLE: Letrozole in the neoadjuvant setting: the P024 trial ABSTRACT: Neoadjuvant chemotherapy trials have consistently reported lower response rates in hormone receptor-positive (HR+) breast cancer when compared with HR− cases. Preoperative endocrine therapy has therefore become a logical alternative and has gai...
Intervention: aromatase inhibitors (AIs) - letrozole Comparator: tamoxifen Outcome: numbers of breast-conserving surgery
1
{"evidence_spans": [{"end": 949, "start": 829, "text": "). Significantly more letrozole-treated patients underwent breast-conserving surgery (45 vs. 35%, respectively; P = 0.02"}, {"end": 15803, "start": 15620, "text": ", respectively; P = 0.042). The proportion of patients able to undergo breast-conserving surgery wa...
TITLE: Letrozole in the neoadjuvant setting: the P024 trial ABSTRACT: Neoadjuvant chemotherapy trials have consistently reported lower response rates in hormone receptor-positive (HR+) breast cancer when compared with HR− cases. Preoperative endocrine therapy has therefore become a logical alternative and has gai...
Intervention: aromatase inhibitors (AIs) - letrozole Comparator: tamoxifen Outcome: reducing tumor proliferation
1
{"evidence_spans": [{"end": 1866, "start": 1706, "text": "). Furthermore, when analyzed by Ki67 immunohistochemistry, letrozole was significantly more effective than tamoxifen in reducing tumor proliferation (P = 0.000"}], "id": "2443", "pmcid": "2001223", "prompt_id": "2443", "split_group_id": "2001223", "votes": {"1"...
TITLE: Changes in Weight, Waist Circumference and Compensatory Responses with Different Doses of Exercise among Sedentary, Overweight Postmenopausal Women ABSTRACT.BACKGROUND: It has been suggested that exercise training results in compensatory mechanisms that attenuate weight loss. However, this has only been ex...
Intervention: non-exercise control group Comparator: groups with exercise energy expenditure of 4 , 8 , or 12 kcal/kg/week (KKW) Outcome: mean weekly steps during the first month
1
{"evidence_spans": [{"end": 15604, "start": 15340, "text": "d 12 KKW group respectively. There were no significant differences in mean weekly steps during the first month among any of the exercise intervention groups, but the non-exercise control group (6098 (2065)) had significantly (P<0.05 for each) more steps compar...
TITLE: Patient Empowerment Improved Perioperative Quality of Care in Cancer Patients Aged ≥ 65 Years – A Randomized Controlled Trial ABSTRACT.PURPOSE: This randomized controlled, clinical prospective interventional trial was aimed at exploring the effect of patient empowerment on short- and long-term outcomes aft...
Intervention: intervention group, i.e. patient empowerment through information booklet and diary keeping Comparator: control group, which received standard care Outcome: numbers overall complications
0
{"evidence_spans": [{"end": 29965, "start": 29836, "text": "spital stay (Fig 5 and Table 3). Of these, 157 (24%) were classified as major complications according to the Clavien Scale (Fig 5"}], "id": "2451", "pmcid": "4574984", "prompt_id": "2451", "split_group_id": "4574984", "votes": {"0": 2}}
TITLE: Patient Empowerment Improved Perioperative Quality of Care in Cancer Patients Aged ≥ 65 Years – A Randomized Controlled Trial ABSTRACT.PURPOSE: This randomized controlled, clinical prospective interventional trial was aimed at exploring the effect of patient empowerment on short- and long-term outcomes aft...
Intervention: intervention group, i.e. patient empowerment through information booklet and diary keeping Comparator: control group, which received standard care Outcome: level of postoperative pain
-1
{"evidence_spans": [{"end": 1998, "start": 1882, "text": " groups. Patients in the intervention group reported significantly less postoperative pain (p = 0.03) than the contr"}], "id": "2452", "pmcid": "4574984", "prompt_id": "2452", "split_group_id": "4574984", "votes": {"-1": 2}}
TITLE: Patient Empowerment Improved Perioperative Quality of Care in Cancer Patients Aged ≥ 65 Years – A Randomized Controlled Trial ABSTRACT.PURPOSE: This randomized controlled, clinical prospective interventional trial was aimed at exploring the effect of patient empowerment on short- and long-term outcomes aft...
Intervention: intervention group, i.e. patient empowerment through information booklet and diary keeping Comparator: control group, which received standard care Outcome: overall mortality
0
{"evidence_spans": [{"end": 33820, "start": 33712, "text": " respectively).Within 30 days after surgery, 4 patients in the intervention and 3 patients in the control gr"}], "id": "2453", "pmcid": "4574984", "prompt_id": "2453", "split_group_id": "4574984", "votes": {"0": 2}}
TITLE: Effect of dietary advanced glycation end products on inflammation and cardiovascular risks in healthy overweight adults: a randomised crossover trial ABSTRACT: Diets high in advanced glycation end products (AGEs) are thought to be detrimental to cardiovascular health. However, there remains uncertainty abo...
Intervention: Low advanced glycation end products (AGEs) diet Comparator: high AGE diet Outcome: mean arterial pressure
0
{"evidence_spans": [{"end": 956, "start": 779, "text": "d. Low AGE diets did not change systolic (p = 0.2) and diastolic blood pressure (p = 0.3), mean arterial pressure (p = 0.8) and pulse pressure (p = 0.2) compared to high AGE die"}], "id": "2456", "pmcid": "5482825", "prompt_id": "2456", "split_group_id": "5482825"...
TITLE: Effect of dietary advanced glycation end products on inflammation and cardiovascular risks in healthy overweight adults: a randomised crossover trial ABSTRACT: Diets high in advanced glycation end products (AGEs) are thought to be detrimental to cardiovascular health. However, there remains uncertainty abo...
Intervention: Low advanced glycation end products (AGEs) diet Comparator: high AGE diet Outcome: total cholesterol
0
{"evidence_spans": [{"end": 1344, "start": 957, "text": "s. Change in total cholesterol (p = 0.3), low-density lipoprotein (p = 0.7), high-density lipoprotein (p = 0.2), and triglycerides (p = 0.4) also did not differ and there was no difference in inflammatory markers: interleukin-6 (p = 0.6), monocyte chemoattractant...
TITLE: Effect of dietary advanced glycation end products on inflammation and cardiovascular risks in healthy overweight adults: a randomised crossover trial ABSTRACT: Diets high in advanced glycation end products (AGEs) are thought to be detrimental to cardiovascular health. However, there remains uncertainty abo...
Intervention: Low advanced glycation end products (AGEs) diet Comparator: high AGE diet Outcome: interleukin-6
0
{"evidence_spans": [{"end": 1344, "start": 957, "text": "s. Change in total cholesterol (p = 0.3), low-density lipoprotein (p = 0.7), high-density lipoprotein (p = 0.2), and triglycerides (p = 0.4) also did not differ and there was no difference in inflammatory markers: interleukin-6 (p = 0.6), monocyte chemoattractant...
TITLE: Effect of dietary advanced glycation end products on inflammation and cardiovascular risks in healthy overweight adults: a randomised crossover trial ABSTRACT: Diets high in advanced glycation end products (AGEs) are thought to be detrimental to cardiovascular health. However, there remains uncertainty abo...
Intervention: Low advanced glycation end products (AGEs) diet Comparator: high AGE diet Outcome: C-reactive protein
0
{"evidence_spans": [{"end": 1344, "start": 957, "text": "s. Change in total cholesterol (p = 0.3), low-density lipoprotein (p = 0.7), high-density lipoprotein (p = 0.2), and triglycerides (p = 0.4) also did not differ and there was no difference in inflammatory markers: interleukin-6 (p = 0.6), monocyte chemoattractant...
TITLE: Effect of Oral Pre-Meal Administration of Betaglucans on Glycaemic Control and Variability in Subjects with Type 1 Diabetes ABSTRACT: We conducted a double-blind placebo-controlled crossover pilot study to investigate the effect of oat betaglucans (β-glucan) on glycaemic control and variability in adults w...
Intervention: Stomacol® tablets (1.53 g of β-glucan) Comparator: placebo (Plac) Outcome: average daily risk range
1
{"evidence_spans": [{"end": 938, "start": 566, "text": "). There was an increase in basic measures of glycaemic control (maximal glucose value 341 \u00b1 15 vs. 378 \u00b1 13 mg/dL for Plac and \u03b2-glucan, p = 0.004), and average daily risk range (62 \u00b1 5 vs. 79 \u00b1 4 mg/dL for Plac and \u03b2-glucan, p = 0.0...
TITLE: The Effects of Aromatherapy on Intensive Care Unit Patients' Stress and Sleep Quality: A Nonrandomised Controlled Trial ABSTRACT.BACKGROUND: Stress has both physiological and psychological effects and can negatively impact patients' treatment and recovery. We examined whether the aromatherapy alleviated p...
Intervention: deep breathing with essential oils Comparator: sleep without receiving the lavender aroma oil Outcome: perceived stress
-1
{"evidence_spans": [{"end": 985, "start": 871, "text": "SULTS:\r\n The experimental group and control group showed a significant difference in perceived stress (F = 60.11, "}, {"end": 1385, "start": 1226, "text": "CLUSIONS:\r\n The results revealed that aromatherapy alleviated stress and improved sleep quality in inten...
TITLE: The Effects of Aromatherapy on Intensive Care Unit Patients' Stress and Sleep Quality: A Nonrandomised Controlled Trial ABSTRACT.BACKGROUND: Stress has both physiological and psychological effects and can negatively impact patients' treatment and recovery. We examined whether the aromatherapy alleviated p...
Intervention: deep breathing with essential oils Comparator: sleep without receiving the lavender aroma oil Outcome: heart rate
-1
{"evidence_spans": [{"end": 1200, "start": 871, "text": "SULTS:\r\n The experimental group and control group showed a significant difference in perceived stress (F = 60.11, p < .001), objective stress index (F = 25.65, p < .001), systolic blood pressure (F = 9.09, p < .001), diastolic blood pressure (F = 2.47, p = .046...
TITLE: Influence of Inter-Set Stretching on Strength, Flexibility and Hormonal Adaptations ABSTRACT: Adequate levels of strength and flexibility are important for the promotion and maintenance of health and functional autonomy as well as safe and effective sports participation. The aim of the present study was to...
Intervention: the static stretching (SSG) Comparator: passive interval (PIG) Outcome: strength in the exercises for leg extension (LE) and Low Row (LR)
0
{"evidence_spans": [{"end": 1630, "start": 1088, "text": "s. Both groups showed significant increases in strength (SSGpre vs. SSGpost; PIGpre vs. PIGpost) in the same exercises for leg extension (LE) and Low Row (LR). Specifically, in the SSG group, the parameters for LE were (p = 0.0015 and ES = 2.28 - Large), and the...
TITLE: Influence of Inter-Set Stretching on Strength, Flexibility and Hormonal Adaptations ABSTRACT: Adequate levels of strength and flexibility are important for the promotion and maintenance of health and functional autonomy as well as safe and effective sports participation. The aim of the present study was to...
Intervention: the static stretching (SSG) or passive interval (PIG) Comparator: baseline Outcome: flexibility of joints
1
{"evidence_spans": [{"end": 1752, "start": 1631, "text": "). Both groups showed significant increases in flexibility but in different joints (SSGpre vs. SSGpost; PIGpre vs. PIGpos"}, {"end": 2219, "start": 1631, "text": "). Both groups showed significant increases in flexibility but in different joints (SSGpre vs. SSGp...
TITLE: Post-marathon wearing of Masai Barefoot Technology shoes facilitates recovery from race-induced fatigue: an evaluation utilizing a visual analog scale ABSTRACT.PURPOSE: To investigate the potential benefit of post-race wearing of unstable shoes (Masai Barefoot Technology [MBT]) on recovery from marathon ra...
Intervention: trail running shoes Comparator: control Outcome: The subjective fatigue on day 3.
0
{"evidence_spans": [{"end": 8909, "start": 8836, "text": "<0.05) or the TR group (P<0.05). No difference between the CON and TR gro"}], "id": "2501", "pmcid": "4266420", "prompt_id": "2501", "split_group_id": "4266420", "votes": {"0": 2}}
TITLE: A randomized, double-blind, prospective, placebo-controlled study of the efficacy of a diet supplemented with curcuminoids extract, hydrolyzed collagen and green tea extract in owner’s dogs with osteoarthritis ABSTRACT.BACKGROUND: We have previously demonstrated that a mixture of Curcuminoids extract, hydr...
Intervention: an experimental diet supplemented with Curcuminoids extract, hydrolyzed COllagen and green Tea extract (CCOT) Comparator: an experimental diet (control) Outcome: change in dogs' body weight
0
{"evidence_spans": [{"end": 21937, "start": 21824, "text": "ULTS.TOLERANCE:\r\nThe CCOT diet was well tolerated. There was no significant change in dogs' body weight nor evide"}], "id": "2502", "pmcid": "5738810", "prompt_id": "2502", "split_group_id": "5738810", "votes": {"0": 2}}
TITLE: A randomized, double-blind, prospective, placebo-controlled study of the efficacy of a diet supplemented with curcuminoids extract, hydrolyzed collagen and green tea extract in owner’s dogs with osteoarthritis ABSTRACT.BACKGROUND: We have previously demonstrated that a mixture of Curcuminoids extract, hydr...
Intervention: an experimental diet supplemented with Curcuminoids extract, hydrolyzed COllagen and green Tea extract (CCOT) Comparator: an experimental diet (control) Outcome: PVF change with time
0
{"evidence_spans": [{"end": 22748, "start": 22469, "text": "and CCOT groups at T0 (p = 0.618) and T3 (p = 0.953). There was no significant PVF change with time in control group (T0: 69.65 \u00b1 4.33% BW; T3: 69.63 \u00b1 3.18% BW; p = 0.999) and in CCOT group (T0: 61.81 \u00b1 2.52% BW; T3: 67.44 \u00b1 3.32% BW; p = ...
TITLE: A randomized, double-blind, prospective, placebo-controlled study of the efficacy of a diet supplemented with curcuminoids extract, hydrolyzed collagen and green tea extract in owner’s dogs with osteoarthritis ABSTRACT.BACKGROUND: We have previously demonstrated that a mixture of Curcuminoids extract, hydr...
Intervention: an experimental diet supplemented with Curcuminoids extract, hydrolyzed COllagen and green Tea extract (CCOT) Comparator: an experimental diet (control) Outcome: Pain at manipulation
-1
{"evidence_spans": [{"end": 1042, "start": 909, "text": "oups. After 3 months of feeding, there was a significant reduction of pain at manipulation in the CCOT group, but not in the control "}, {"end": 24245, "start": 23964, "text": "DY.RESULTS.SUBJECTIVE MEASUREMENT: VETERINARY EVALUATION:\r\nPain at manipulation was ...
TITLE: A randomized, double-blind, prospective, placebo-controlled study of the efficacy of a diet supplemented with curcuminoids extract, hydrolyzed collagen and green tea extract in owner’s dogs with osteoarthritis ABSTRACT.BACKGROUND: We have previously demonstrated that a mixture of Curcuminoids extract, hydr...
Intervention: an experimental diet supplemented with Curcuminoids extract, hydrolyzed COllagen and green Tea extract (CCOT) Comparator: an experimental diet (control) Outcome: lameness, pain at palpation and joint mobility at T0 and T3
0
{"evidence_spans": [{"end": 1263, "start": 1104, "text": "diet. The three other parameters evaluated by veterinary subjective assessment (lameness, pain at palpation and joint mobility) did not show statistical differ"}, {"end": 24377, "start": 24246, "text": "at manipulation depended on the diet (p = 0.036) (Fig. 4). ...
TITLE: The impact of Cognitive Processing Therapy on stigma among survivors of sexual violence in eastern Democratic Republic of Congo: results from a cluster randomized controlled trial ABSTRACT.BACKGROUND: Sexual violence is associated with a multitude of poor physical, emotional, and social outcomes. Despite r...
Intervention: Cognitive Processing Therapy Comparator: individual support Outcome: felt stigma after treatment
-1
{"evidence_spans": [{"end": 1698, "start": 1516, "text": "ESULTS:\r\nParticipants receiving CPT experienced moderate reductions in felt stigma relative to those in individual support (Cohen's D = 0.44, p = value = 0.02) following the end of t"}, {"end": 23439, "start": 23198, "text": "ence that reached statistical sign...
TITLE: A randomized, double-blind, prospective, placebo-controlled study of the efficacy of a diet supplemented with curcuminoids extract, hydrolyzed collagen and green tea extract in owner’s dogs with osteoarthritis ABSTRACT.BACKGROUND: We have previously demonstrated that a mixture of Curcuminoids extract, hydr...
Intervention: an experimental diet supplemented with Curcuminoids extract, hydrolyzed COllagen and green Tea extract (CCOT) Comparator: an experimental diet (control) Outcome: Coll2–1 and Coll2–1 NO2 serum concentrations
0
{"evidence_spans": [{"end": 26021, "start": 25898, "text": " **p < 0.01\r\n\r\n\r\nBODY.RESULTS.OBJECTIVE MEASUREMENT: OA BIOMARKERS:\r\nColl2\u20131 and Coll2\u20131 NO2 serum concentrations were not "}, {"end": 26132, "start": 25898, "text": " **p < 0.01\r\n\r\n\r\nBODY.RESULTS.OBJECTIVE MEASUREMENT: OA BIOMARKERS:\r...
TITLE: Shear Bond Strength of Superficial, Intermediate and Deep Dentin ABSTRACT.BACKGROUND:: This in vitro study is intended to compare the shear bond strength of recent self-etching primers to superficial, intermediate, and deep dentin levels. ABSTRACT.MATERIALS AND METHODS:: All teeth were sectioned at va...
Intervention: All Bond 2 (Group III) Comparator: Group I, II and Group III (positive control) Outcome: bond strength values
1
{"evidence_spans": [{"end": 1093, "start": 831, "text": "SULTS::\r\nComparing the shear bond strength values, All Bond 2 (Group III) demonstrated fairly higher bond strength values at different levels of dentin. Generally comparing All Bond 2 with the other two experimental groups revealed highly significant statistica...
TITLE: Intravitreal ziv-aflibercept for macular edema following retinal vein occlusion ABSTRACT.AIM: To report the efficacy of intravitreal ziv-aflibercept injections in eyes with macular edema due to retinal vein occlusions (RVOs). ABSTRACT.METHODS: Consecutive patients with persistent or recurrent macular e...
Intervention: intravitreal injections of ziv-aflibercept (1.25 mg/0.05 mL) Comparator: baseline Outcome: central macular thickness (CMT) at 1 month and at 4 months
-1
{"evidence_spans": [{"end": 1192, "start": 1046, "text": "rolled. The mean \u00b1 standard deviation CMT decreased from 604\u00b1199 \u03bcm at baseline to 319\u00b1115 \u03bcm (P=0.001) at 1 month and to 351\u00b1205 \u03bcm (P=0.026) at "}, {"end": 1342, "start": 1193, "text": " months. The mean BCVA did not improve ...
TITLE: A 12-Week Commercial Web-Based Weight-Loss Program for Overweight and Obese Adults: Randomized Controlled Trial Comparing Basic Versus Enhanced Features ABSTRACT.BACKGROUND: The development and use of Web-based programs for weight loss is increasing rapidly, yet they have rarely been evaluated using random...
Intervention: Standard version or enhanced version of commercial Web-based weight-loss program Comparator: Wait-list control group Outcome: Body mass index
-1
{"evidence_spans": [{"end": 1497, "start": 1301, "text": "t 12 weeks. Intention-to-treat analysis showed that both intervention groups reduced their BMI compared with the controls (basic: \u20130.72, SD 1.1 kg/m2, enhanced: \u20131.0, SD 1.4, control: 0.15, SD 0.8"}], "id": "2541", "pmcid": "3376507", "prompt_id": "254...
TITLE: A 12-Week Commercial Web-Based Weight-Loss Program for Overweight and Obese Adults: Randomized Controlled Trial Comparing Basic Versus Enhanced Features ABSTRACT.BACKGROUND: The development and use of Web-based programs for weight loss is increasing rapidly, yet they have rarely been evaluated using random...
Intervention: Standard version or enhanced version of commercial Web-based weight-loss program Comparator: Wait-list control group Outcome: Improvement in waist-to-height ratio
1
{"evidence_spans": [{"end": 1905, "start": 1301, "text": "t 12 weeks. Intention-to-treat analysis showed that both intervention groups reduced their BMI compared with the controls (basic: \u20130.72, SD 1.1 kg/m2, enhanced: \u20131.0, SD 1.4, control: 0.15, SD 0.82; P < .001) and lost significant weight (basic: \u20132...
TITLE: Treatment of Rockwood type III acromioclavicular joint dislocation using autogenous semitendinosus tendon graft and endobutton technique ABSTRACT.BACKGROUND: The aim of this study was to evaluate the therapeutic effect of autogenous semitendinosus graft and endobutton technique, and compare with hook plate...
Intervention: Group B with autogenous semitendinosus graft and endobutton technique Comparator: Group A was treated using a hook plate Outcome: mean scores of Constant–Murley score
1
{"evidence_spans": [{"end": 1057, "start": 908, "text": "ESULTS:\r\nResults indicated that patients in Group B showed higher mean scores (90.3\u00b15.4) than Group A (80.4\u00b111.5) in terms of Constant\u2013Murley score ("}], "id": "2552", "pmcid": "4714728", "prompt_id": "2552", "split_group_id": "4714728", "votes":...
TITLE: Treatment of Rockwood type III acromioclavicular joint dislocation using autogenous semitendinosus tendon graft and endobutton technique ABSTRACT.BACKGROUND: The aim of this study was to evaluate the therapeutic effect of autogenous semitendinosus graft and endobutton technique, and compare with hook plate...
Intervention: Group B with autogenous semitendinosus graft and endobutton technique Comparator: Group A was treated using a hook plate Outcome: activities
1
{"evidence_spans": [{"end": 1188, "start": 1058, "text": "=0.001). Group B patients scored higher in terms of pain (P=0.002), activities (P=0.02), range of motion (P<0.001), and strength ("}, {"end": 8944, "start": 8673, "text": "the Constant\u2013Murley score (P<0.05). Table 2 shows that patients treated with the auto...
TITLE: Recombinant Erythropoietin in Humans Has a Prolonged Effect on Circulating Erythropoietin Isoform Distribution ABSTRACT: The membrane-assisted isoform immunoassay (MAIIA) quantitates erythropoietin (EPO) isoforms as percentages of migrated isoforms (PMI). We evaluated the effect of recombinant human EPO (r...
Intervention: low-dose Epoetin beta (5000 IU on days 1, 3, 5, 7, 9, 11 and 13) Comparator: placebo on all days Outcome: percentages of migrated isoforms (PMI) on days 4 and 11
-1
{"evidence_spans": [{"end": 1218, "start": 1108, "text": "). Low-dose Epoetin beta decreased PMI on days 4 and 11 to 46.0 (12.8)% (p<0.00001) and 46.1 (10.4)% (p<0.0000"}, {"end": 20476, "start": 20350, "text": "n all days within the high-dose intervention (p<0.0001). Low-dose Epoetin beta decreased PMI on days 4 and 1...
TITLE: Recombinant Erythropoietin in Humans Has a Prolonged Effect on Circulating Erythropoietin Isoform Distribution ABSTRACT: The membrane-assisted isoform immunoassay (MAIIA) quantitates erythropoietin (EPO) isoforms as percentages of migrated isoforms (PMI). We evaluated the effect of recombinant human EPO (r...
Intervention: high-dose Epoetin beta (30.000 IU on days 1, 2 and 3 and placebo on days 5, 7, 9, 11 and 13) and low-dose Epoetin beta (5000 IU on days 1, 3, 5, 7, 9, 11 and 13), Comparator: placebo on all days Outcome: percentages of migrated isoforms (PMI) on day 25
-1
{"evidence_spans": [{"end": 1375, "start": 1219, "text": "). In both rhEPO groups, PMI on day 25 was still decreased (high-dose Epoetin beta: 72.9 (19.4)% (p = 0.029); low-dose Epoetin beta: 73.1 (17.8)% (p = 0.039"}, {"end": 20808, "start": 20622, "text": "ys significantly lower compared with day 25 (p<0.00001). In bo...
TITLE: Are frail elderly patients treated in a CGA unit more satisfied with their hospital care than those treated in conventional acute medical care? ABSTRACT.OBJECTIVES: Our aim was to study whether the acute care of frail elderly patients directly admitted to a comprehensive geriatric assessment (CGA) unit is ...
Intervention: comprehensive geriatric assessment (CGA) group Comparator: conventional care group Outcome: numbers of positively response to the following question about the hospitalization: "Are you satisfied with the information you received on your diseases and medication?�
1
{"evidence_spans": [{"end": 15877, "start": 15345, "text": "sis of the dichotomized responses of the questionnaire is shown in Table 4. Significantly more patients in the intervention group responded positively to the following three questions: \"Did you get the nursing from the ward staff that you needed?\" (p=0.003),...
TITLE: Are frail elderly patients treated in a CGA unit more satisfied with their hospital care than those treated in conventional acute medical care? ABSTRACT.OBJECTIVES: Our aim was to study whether the acute care of frail elderly patients directly admitted to a comprehensive geriatric assessment (CGA) unit is ...
Intervention: comprehensive geriatric assessment (CGA) group Comparator: conventional care group Outcome: numbers of positively response to the following question about the hospitalization: "Are you satisfied with the planning before discharge from the hospital?�
0
{"evidence_spans": [{"end": 2120, "start": 1554, "text": "response rate was 61%. In unadjusted analyses, significantly more patients in the intervention group responded positively to the following three questions about the hospitalization: \"Did you get the nursing from the ward staff that you needed?\" (p=0.003), \"Ar...
TITLE: Patient Empowerment Improved Perioperative Quality of Care in Cancer Patients Aged ≥ 65 Years – A Randomized Controlled Trial ABSTRACT.PURPOSE: This randomized controlled, clinical prospective interventional trial was aimed at exploring the effect of patient empowerment on short- and long-term outcomes aft...
Intervention: intervention group, i.e. patient empowerment through information booklet and diary keeping - females Comparator: control group, which received standard care - females Outcome: Health-Related Quality of Life at 12 month - females
0
{"evidence_spans": [{"end": 1688, "start": 1506, "text": "14 day). There were no significant differences between the intervention and the control groups in postoperative LOS (p = 0.99) or global HRQoL after one year (women: p = 0.54, men: p"}, {"end": 27920, "start": 27750, "text": "nd n = 216 in the control group. Mea...
TITLE: Patient Empowerment Improved Perioperative Quality of Care in Cancer Patients Aged ≥ 65 Years – A Randomized Controlled Trial ABSTRACT.PURPOSE: This randomized controlled, clinical prospective interventional trial was aimed at exploring the effect of patient empowerment on short- and long-term outcomes aft...
Intervention: intervention group, i.e. patient empowerment through information booklet and diary keeping - males Comparator: control group, which received standard care - males Outcome: Health-Related Quality of Life at 12 month - males
0
{"evidence_spans": [{"end": 1688, "start": 1506, "text": "14 day). There were no significant differences between the intervention and the control groups in postoperative LOS (p = 0.99) or global HRQoL after one year (women: p = 0.54, men: p"}, {"end": 28093, "start": 27921, "text": "roup (p = 0.74) (Fig 3). The global ...
TITLE: Comparing the Effects of Hot Pack and Lukewarm-Water-Soaked Gauze on Postoperative Urinary Retention; A Randomized Controlled Clinical Trial ABSTRACT.BACKGROUND:: Urinary retention is a common postoperative complication that mandates urinary catheterization. Urinary catheterization is associated with diffe...
Intervention: hot pack and water soaked gauze Comparator: control groups Outcome: Urinary Retention relief
1
{"evidence_spans": [{"end": 2149, "start": 1850, "text": ".RESULTS::\r\nRespectively, 59.5%, 71.4%, and 7.1% of patients in the hot pack, the soaked gauze, and the control groups experienced relief from urinary retention and the bladder was emptied. There was a significant difference among study groups in percentage of...
TITLE: Effect of dietary advanced glycation end products on inflammation and cardiovascular risks in healthy overweight adults: a randomised crossover trial ABSTRACT: Diets high in advanced glycation end products (AGEs) are thought to be detrimental to cardiovascular health. However, there remains uncertainty abo...
Intervention: Low advanced glycation end products (AGEs) diet Comparator: high AGE diet Outcome: systolic blood pressure
0
{"evidence_spans": [{"end": 955, "start": 779, "text": "d. Low AGE diets did not change systolic (p = 0.2) and diastolic blood pressure (p = 0.3), mean arterial pressure (p = 0.8) and pulse pressure (p = 0.2) compared to high AGE di"}, {"end": 956, "start": 779, "text": "d. Low AGE diets did not change systolic (p = 0....
TITLE: Effect of dietary advanced glycation end products on inflammation and cardiovascular risks in healthy overweight adults: a randomised crossover trial ABSTRACT: Diets high in advanced glycation end products (AGEs) are thought to be detrimental to cardiovascular health. However, there remains uncertainty abo...
Intervention: Low advanced glycation end products (AGEs) diet Comparator: high AGE diet Outcome: pulse pressure
0
{"evidence_spans": [{"end": 956, "start": 779, "text": "d. Low AGE diets did not change systolic (p = 0.2) and diastolic blood pressure (p = 0.3), mean arterial pressure (p = 0.8) and pulse pressure (p = 0.2) compared to high AGE die"}], "id": "2457", "pmcid": "5482825", "prompt_id": "2457", "split_group_id": "5482825"...
TITLE: Effect of dietary advanced glycation end products on inflammation and cardiovascular risks in healthy overweight adults: a randomised crossover trial ABSTRACT: Diets high in advanced glycation end products (AGEs) are thought to be detrimental to cardiovascular health. However, there remains uncertainty abo...
Intervention: Low advanced glycation end products (AGEs) diet Comparator: high AGE diet Outcome: tumour necrosis factor α
0
{"evidence_spans": [{"end": 1344, "start": 957, "text": "s. Change in total cholesterol (p = 0.3), low-density lipoprotein (p = 0.7), high-density lipoprotein (p = 0.2), and triglycerides (p = 0.4) also did not differ and there was no difference in inflammatory markers: interleukin-6 (p = 0.6), monocyte chemoattractant...